Zolgensma Infusion For Spinal Muscular Atrophy, Outpatient
Zolgensma is a one-time genetic therapy for patients under two years old diagnosed with Spinal Muscular Atrophy (SMA), a condition in which the survival motor neuron 1 (SMN1) gene is missing or functioning poorly. Zolgensma delivers a new gene to produce survival motor neuron protein and preserve motor neuron cells throughout the body, supporting and sustaining muscle function and stopping the progression of SMA.
1 Result(s)
Distance
2252 Miles
Details